Provides an overview of current cancer statistics and explains who is at risk for developing cancer

Outlines how clinical pathways are developed and used in oncology care decision making

Outlines how clinical guidelines are developed and guide in oncology care decision making

Part 1 of our landscape series provides a big picture on cancer patients today and the novel therapies used to treat them

Follows an outpatient specialty drug used in cancer from drug manufacturer to patient

Follows a physician-administered drug used in cancer through the pharmaceutical supply chain

Explains the basics of a joining a GPO, the contracting process, and benefits for providers

Provides key information on the benefits of electronic health records, especially in relation to quality reporting and the shift to value-based care

Explains the basics of MCOs and roles of key decision makers

A deep dive into Medicare infrastructure, including an explanation of how Medicare reimbursement works across different settings

Details Medicare Part B services and physician reimbursement

PATHWAYS: Federal Payer • Commercial Payers • Reimbursement • Payment Reform • New Hire Curriculum

Explores the dynamics of Medicare Part D prescription drug programs

Part 2 of our landscape series gives a look inside an oncology practice and how it functions, including how patients are administered care and how costs are managed

Exploration of the term “quality” in the delivery of cancer care, and how it helps identify value based, versus volume based, models of cancer care

Part 3 in our landscape series explores the larger trends affecting oncology practices and how they treat cancer patient today

Defines the various terms used in physician-administered drug reimbursement

Provides basic knowledge on the two government-sponsored payment programs